J Mitra launches COVID-19 total antibody detection Elisa test

J Mitra & Co. Pvt. Ltd. has launched its state-of-the-art COVID-19 test kit in the Indian market. Based on the double-sandwich Elisa technology, the test kit is known as COVID-19 [IgM, IgG, IgA] Microlisa. It is a serology-based total antibody (IgM, IgG, IgA) detection assay. This factor makes the J Mitra corona test kit superior and more accurate than other similar tests available in the market. It is a detection assay for the indirect diagnosis of past exposure to COVID-19. All the COVID-19 antibodies are detected without a differentiation in antibodies, and this is the reason contributing to the superior performance of this test. Elisa tests are highly sensitive and specific, and detect the COVID-19 antibodies in patient blood samples. 96 tests can be performed in one single go (using an instrument), and the test results are available within 90 minutes. The COVID-19 [IgM, IgG, IgA] Microlisa Elisa test kit has cleared all government parameters, and received all necessary approvals, including Indian Council of Medical Research (ICMR) and Drug Controller General of India (DCGI).